« Home | Solubility Properties of Organic Compounds Course ... » | Effects of replacement of maize with dried leaves ... » | Feeding of spinach or sweet-potato leaves and grow... » | Utilization of ensiled sweet potato (Ipomoea batat... » | 高胡萝卜素含量品种徐22-5&徐薯18 » | SWEET POTATO VARIETIES » | 国内外甘薯研究现状--徐州甘薯研究中心育种室 » | Phytochemicals and pulp from vegetable crops waste » | The Need for Lutein® » | Consumption of purple sweet potato leaves modulate... » 

星期五, 三月 31, 2006 

Extended Hildebrand approach: solubility of caffeine in dioxane-water mixtures.

J Pharm Sci. 1980 Jun;69(6):659-61.
Adjei A, Newburger J, Martin A.
The solubility of caffeine in various dioxane-water mixtures was analyzed in terms of solute-solvent interactions using a modified version of the Hildebrand treatment for regular solutions. The solubility equation employs a term (W) to replace the geometric mean (c1c2)1/2, where c1 and c2 are the cohesive energy densities for the solvent and solute, respectively. The new equation provides an accurate prediction of solubility once the interaction energy, W, is obtained. In this case, the energy term is regressed against a polynomial in delta 1 of the binary mixture. A quartic expression of W in terms of the solvent solubility parameter was found for predicting the solubility of caffeine in dioxane-water mixtures. The expression yields an error in mole fraction solubility of less than 3%, a value approximating that of the experimentally determined solubility. The one exception to a good fit is near the maximum solubility, where a depression or valley occurs between the two peaks in solubility data; at this point, the theoretical equation predicts the solubility within approximately 9%. The new model also may be used to estimate the solubility of drug molecules employing the volume fraction of water in the solvent mixture instead of the composite solubility parameter, delta 1. The method has potential usefulness in preformulation and formulation studies during which solubility determination is important for drug design.